Doppler and Biological Second Trimester Placental Insufficiency Screening (ARTULEP)

• ClinicalTrials.gov Identifier: NCT00465634
• Recruitment Status: Completed
• First Posted: April 25, 2007
• Last Update Posted: August 9, 2013
• Sponsor: University Hospital, Tours
• Information provided by: University Hospital, Tours

Study Description

Brief Summary:

To assess the role of uterine artery and maternal serum leptin and lipids and their combination in screening for pre-eclampsia and small-for-gestational-age (SGA) fetuses at 20-24 weeks of gestation

Condition or disease
Pre-Eclampsia; Fetal Growth Retardation; Placental Insufficiency

Detailed Description:

Pre-eclampsia (PE) and intrauterine growth restriction (IUGR) are known as major factors in perinatal morbidity and mortality. Routine antenatal care is focused on the detection of women at increased risk to apply this population a program of careful monitoring and appropriate intervention.

Uterine artery Doppler during anomaly scan at 20 to 24 weeks in selected women at increased risk, has proved to be accurate to detect those who will develop PE or IUGR during the second half of pregnancy. Studies have reported detection rate of 50-70% for a 5% false positive rate in women developing early pre-eclampsia.

A variety of proteins and hormones have been studied as potential markers for pre-eclampsia. Among these protein serum placental leptin has demonstrated higher levels in pregnant women who will subsequently develop pre-eclampsia. However, screening performance of leptin detection in early pregnancy has never been assessed.

Our study is aimed to evaluate the performance of serum leptin measurement in association with uterine artery Doppler as a screening too for placental insufficiency.

Study Design

• Study Type: Observational
• Actual Enrollment: 235 participants
• Observational Model: Case-Only
• Time Perspective: Prospective
• Official Title: Screening for Placental Insufficiency by a Combination of Second Trimester Uterine Artery Doppler and Maternal Serum Leptin and Lipids
• Study Start Date: May 2003
• Actual Primary Completion Date: June 2007
• Actual Study Completion Date: June 2007

Groups and Cohorts

Outcome Measures

Eligibility Criteria

• Ages Eligible for Study: 18 Years to 45 Years (Adult)
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: No
• Sampling Method: Non-Probability Sample

Study Population

women at increased risk of pre-eclampsia (PE) and intrauterine growth restriction (IUGR)

Criteria

Inclusion Criteria:

• Chronic hypertension under medication
• Diabetes
• Thrombophilia
• Previous history of pre-eclampsia
• Previous history of unexplained stillbirth
• Previous history of placental abruption
• Previous history of SGA (< 10th centile)
• History of pre-eclampsia or chronic hypertension before 45 years in the mother or a sister
• Obesity (BMI>30)
• Nulliparous after 40 years
• Assisted conception with donor

Exclusion Criteria:

• Multiple pregnancy
• Complicated pregnancy with a high probability of required fetal extraction before term
• Pregnancy requiring termination
• Unability to understand the study

Contacts and Locations

Locations

France

Olympe de Gouges Women Health Centre, Bretonneau University Hospital

Tours, France, 37044

Sponsors and Collaborators

University Hospital, Tours

Investigators

• Principal Investigator: Franck Perrotin, MD-PhD; Tours University Hospital

More Information

Publications:

Papageorghiou AT, Leslie K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol. 2007 Apr;19(2):103-9. Review.

Guven MA, Ertas IE, Kilinc M, Coskun A, Ekerbicer H. Combining mid-trimester maternal plasma homocysteine with uterine artery doppler velocimetry: is it useful? Arch Gynecol Obstet. 2007 Jun;275(6):439-43. Epub 2006 Nov 17.

Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol. 2006 Jun;27(6):658-63.

Tommaselli GA, Pighetti M, Nasti A, D'Elia A, Guida M, Di Carlo C, Bifulco G, Nappi C. Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks' gestation as markers for the development of pre-eclampsia. Gynecol Endocrinol. 2004 Sep;19(3):160-5.

• Responsible Party: Pr Franck Perrotin, CHRU de Tours
• ClinicalTrials.gov Identifier: NCT00465634
• Other Study ID Numbers: PHRR02-FP/ARTULEP
• First Posted: April 25, 2007
• Last Update Posted: August 9, 2013
• Last Verified: August 2013

Keywords provided by University Hospital, Tours:

Screening; uterine artery Doppler; HELLP syndrome; abruption

Additional relevant MeSH terms:

Eclampsia; Pre-Eclampsia; Fetal Growth Retardation; Placental Insufficiency; Hypertension, Pregnancy-Induced; Pregnancy Complications; Fetal Diseases; Growth Disorders; Pathologic Processes; Placenta Diseases